Moreover, since anti-parasitic treatment results in the worsening of helminth-infection symptoms, its use leads to a significant increase in clinical and radiological MS activities, an increase in the number of IFN-γ and IL-12 producing cells, and a reduction in regulatory signals after three months of anti-helminths treatment [23]. The gene discussed is IFNG; the disease is myeloid sarcoma.